TNFSF10 and breast carcinoma: We have shown that TRAIL is able to suppress the clonal expansion of all six breast cancer cell lines tested, irrespective of their overall sensitivity to TRAIL, and furthermore that TRAIL is able to target directly the stem-like sub-populations in four of these cell lines.